ABSTRACT
The human genome project has generated data unprecedented in its volume and in the promise that it holds in providing a better understanding of the complexity of biological systems. This entry discusses the role of certain technologies in the pharmaceutical sciences, specifically the application of genomic technologies in assessing the importance of human genetic variation in drug response and also in identifying networks of genes which determine the efficacy and toxicity of drug therapies.
